Docetaxel

NDC 0409-2026 · Hospira, Inc.

Generic nameDOCETAXEL ANHYDROUS

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DOCETAXEL ANHYDROUS

Strength10 mg/mL

Pharmacologic classMicrotubule Inhibition [PE], Microtubule Inhibitor [EPC]

Marketing categoryNDA

Packages

0409-2026-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-2026-01) / 2 mL in 1 VIAL, SINGLE-DOSE

J9232 — Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mg Medicare Part B payment limit (ASP + 6%): $0.51

FDA lists these products with the same active ingredient.

0409-0016 — DOCETAXEL ANHYDROUS, 0409-0201 — DOCETAXEL ANHYDROUS, 0409-1732 — DOCETAXEL ANHYDROUS, 0409-7870 — DOCETAXEL ANHYDROUS, 16729-267 — docetaxel, 25021-245 — Docetaxel Anhydrous, 25021-254 — Docetaxel Anhydrous, 43066-044 — Docetaxel, 43066-046 — Docetaxel, 43066-048 — Docetaxel, 46708-678 — Docetaxel, 47335-323 — Docetaxel, 47335-895 — Docetaxel, 47335-939 — Docetaxel, 55150-378 — Docetaxel, 55150-379 — Docetaxel, 55150-380 — Docetaxel, 62332-678 — Docetaxel, 67457-531 — DOCETAXEL ANHYDROUS, 67457-532 — DOCETAXEL ANHYDROUS, +15 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.